NIH-funded research R01 grant

Why under-the-tongue buprenorphine may harm teeth

Official title: Elucidating High Oral Fluid Exposure Mechanisms of Buprenorphine to Reduce Dental Caries

Funded at University of Houston · NIH-11354393 · Data updated 2026-11-12

This project looks at how buprenorphine taken under the tongue may cause tooth damage in people treated for opioid use disorder.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 21, 2023
Project endSeptember 20, 2028
Funding year2025
Award (this year)$710,155
NIH project number4R01DE033321-02
Project IDNIH-11354393 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be people currently taking or who have recently taken sublingual buprenorphine, especially those with new or worsening dental problems.

Less likely to help

People who do not use sublingual buprenorphine or whose dental issues have clear non-drug causes may not benefit from this work.

What this research studies

If you take buprenorphine under the tongue, researchers will study how high drug levels in saliva interact with teeth and oral tissues. The team will measure buprenorphine concentrations in oral fluids, use lab and animal models to track how the drug distributes in the mouth, and examine direct effects on tooth structure. They will also test possible ways to block or reduce the tooth-damaging effects so future treatments could be safer.

Why it matters

Potential benefit: If successful, this work could lead to ways to prevent or reduce tooth damage for people using sublingual buprenorphine.

How similar studies have gone: Reports and an FDA warning have documented tooth problems with buprenorphine use, but the specific biological mechanisms are not well understood and this approach is relatively novel.

Where this research is happening

  • University of Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Hu, Ming — University of Houston
  • Study coordinator: Hu, Ming

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.